GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have changed metabolic medicine. Tens of millions of prescriptions have been written, and a large percentage of those users also take dietary supplements.
This creates a practical problem that most prescribing physicians don't spend much time on: which supplements are helpful, which are unnecessary, and which could genuinely cause harm when combined with GLP-1 therapy?
The reduced food intake alone creates nutritional gaps that didn't exist before. And the altered gut physiology — slower gastric emptying, reduced acid secretion, changed motility — means absorption of everything you swallow is different now. Meanwhile, the supplement industry is aggressively marketing "GLP-1 support" products, some of which are redundant and others outright dangerous.
Here's what the evidence actually says.
Related: Use our GLP-1 Protein Calculator to dial in daily protein targets, and check our Supplement Stack Audit for interaction and timing checks.
Why GLP-1 Users Need to Rethink Their Stack
Before getting into specific supplements, it helps to understand why being on a GLP-1 medication changes the equation.
You are eating less. Most users on therapeutic doses of semaglutide or tirzepatide report appetite reductions of 30–50%. That means your total nutrient intake from food drops substantially. Micronutrients you used to get passively from a full diet may now be insufficient.
Your gut moves differently. GLP-1 agonists slow gastric emptying by design — that is part of how they work. But slower transit also means supplements sit in your stomach longer, affecting how much is absorbed and when. Fat-soluble vitamins, minerals that compete for absorption, and time-sensitive compounds are all impacted.
Muscle loss is a real risk. The STEP trials documented that roughly 40% of weight lost on semaglutide was lean mass, not just fat. This makes protein intake and muscle-supportive nutrients more important than they would be on a standard diet.
Understanding these three shifts is the foundation for building a supplement stack that actually works on GLP-1 therapy, rather than just continuing whatever you were taking before.
Supplements to Prioritize on GLP-1 Medications
Protein Supplements
This is the single most important nutritional priority for anyone on GLP-1 therapy. With appetite suppressed and food volume reduced, hitting adequate protein through whole foods alone becomes genuinely difficult for many users.
Research suggests that protein intake of 1.2–1.6 g/kg of body weight per day may help preserve lean mass during weight loss. For a 200-pound person, that is roughly 110–145 grams daily. When you are eating 40% less food overall, that target is hard to reach without supplementation.
Whey protein isolate is the most bioavailable and well-studied option. If dairy is an issue — and GLP-1-related GI sensitivity can make dairy less tolerable — plant-based blends with rice and pea protein provide a reasonable alternative with a complete amino acid profile.
Timing note: Some users report better tolerance taking protein shakes between meals rather than with meals, since the delayed gastric emptying can make large, protein-heavy meals feel uncomfortably slow to digest.
Use the GLP-1 Protein Calculator to estimate your specific daily target.
Vitamin D
Vitamin D deficiency is already widespread in the general population — roughly 42% of U.S. adults have insufficient levels according to NHANES data. Reduced food intake on GLP-1 medications makes this worse, since fewer dietary sources of vitamin D (fatty fish, fortified dairy, eggs) are consumed.
Vitamin D is fat-soluble, which means it requires dietary fat for absorption. Many GLP-1 users eat significantly less fat, creating a double problem: less dietary vitamin D and less fat to absorb what they do take.
A maintenance dose of 2,000–4,000 IU daily is reasonable for most adults, though individual needs vary based on baseline levels, body weight, sun exposure, and skin pigmentation. Testing 25-hydroxyvitamin D blood levels is the only way to know where you stand — and it is inexpensive.
Absorption tip: Take vitamin D with whatever meal contains the most fat. Even a tablespoon of olive oil or a handful of nuts significantly improves uptake.
Our Vitamin D Dosage Calculator can help you estimate what level of supplementation may be appropriate.
Vitamin B12
Oral semaglutide (Rybelsus) carries a specific concern here. A pharmacokinetic study published in the Journal of Clinical Pharmacology found that oral semaglutide reduced vitamin B12 absorption by approximately 22% over a 20-week period. The proposed mechanism involves altered intrinsic factor binding in the stomach due to delayed gastric emptying and reduced acid secretion.
Injectable semaglutide and tirzepatide have not shown the same degree of B12 absorption impairment, though the reduced food intake on any GLP-1 medication means dietary B12 sources are lower.
Symptoms of B12 deficiency develop slowly and are easy to miss: fatigue, brain fog, tingling in extremities, and mood changes. For users on long-term GLP-1 therapy, periodic B12 testing (serum B12 plus methylmalonic acid for a more sensitive marker) is a reasonable precaution.
Supplementation options: Methylcobalamin (the active form) at 1,000–2,000 mcg daily, or sublingual forms that bypass GI absorption entirely.
Zinc
Zinc is involved in over 300 enzymatic reactions including immune function, wound healing, testosterone production, and protein synthesis. With reduced food intake, zinc intake often drops below the recommended 11 mg/day for adult men.
Several studies indicate that zinc deficiency accelerates muscle protein breakdown — exactly the opposite of what you want during GLP-1-mediated weight loss where lean mass preservation is already a challenge.
A supplemental dose of 15–30 mg daily (zinc picolinate or zinc bisglycinate for better absorption) may help maintain adequate levels. Take it with food to minimize nausea, which can compound the GI side effects some users already experience on GLP-1 medications.
Do not take zinc and iron at the same time. They compete for the same absorption pathway in the intestine and will reduce each other's uptake. Separate them by at least 2 hours. Similarly, zinc can interfere with copper absorption over time — if supplementing zinc long-term, consider a small copper supplement (1–2 mg) to maintain the zinc-to-copper ratio.
Iron
Iron deficiency may develop gradually on GLP-1 therapy for two reasons: reduced dietary iron from eating less red meat and other iron-rich foods, and reduced stomach acid secretion which impairs non-heme iron absorption.
Not everyone on a GLP-1 medication needs supplemental iron. This is one where testing matters — serum ferritin and a complete blood count can identify whether you are actually deficient. Unnecessary iron supplementation carries its own risks, including GI distress (which stacks poorly with GLP-1 side effects) and potential oxidative stress from excess iron stores.
If supplementation is indicated: 18–27 mg of elemental iron daily (ferrous bisglycinate is better tolerated than ferrous sulfate), taken with vitamin C to enhance absorption and on an empty stomach if tolerated. If the GI side effects are too much, taking it with a small meal is an acceptable trade-off.
Probiotics
GLP-1 medications alter gut motility and the intestinal environment in ways that can shift the microbiome. Some users report constipation, bloating, or irregular digestion that persists for months. A well-formulated probiotic may help manage these GI side effects.
The evidence is strongest for strains with documented efficacy in controlled trials — Lactobacillus rhamnosus GG, Saccharomyces boulardii, and multi-strain formulations with at least 10 billion CFU. Generic "probiotic blend" products without specified strains and colony counts are often marketing exercises.
Practical note: Probiotics may be more useful in the first 3–6 months of GLP-1 therapy when GI side effects tend to be most pronounced. Whether they provide long-term gut health benefits on continued therapy is less clear from current data.
For more on strain selection and evidence, see our deep dive on whether probiotics actually work.
Magnesium
Many GLP-1 users report muscle cramps, poor sleep, or increased anxiety — symptoms that overlap with magnesium deficiency. Reduced food intake lowers dietary magnesium, and the electrolyte shifts from rapid weight loss can accelerate depletion.
Magnesium glycinate (for sleep and relaxation) or magnesium L-threonate (for cognitive effects) are better-absorbed forms compared to magnesium oxide, which has poor bioavailability and can worsen GI symptoms.
A dose of 200–400 mg of elemental magnesium daily is a reasonable starting point. Our Magnesium Dosage Calculator can help you determine the right form and amount for your goals.
Omega-3 Fatty Acids
Reduced food intake often means reduced consumption of fatty fish and other omega-3 sources. EPA and DHA have well-documented anti-inflammatory effects, and emerging research suggests they may help modulate some of the cardiovascular benefits seen with GLP-1 therapy.
A combined EPA/DHA dose of 1,000–2,000 mg daily from a quality fish oil or algal oil source is consistent with most research protocols. Take with food containing fat for optimal absorption.
The Levothyroxine Absorption Issue
This is not a supplement — it is a prescription medication — but it is important enough to flag here because many GLP-1 users also take levothyroxine for hypothyroidism, and the interaction is clinically significant.
A pharmacokinetic study found that oral semaglutide increased levothyroxine exposure (AUC) by approximately 33%. This means if you take both oral semaglutide and levothyroxine, your thyroid medication may be significantly more potent than your prescribing physician intended. This could push you into a hyperthyroid state with symptoms including rapid heart rate, anxiety, tremor, and weight loss beyond what the GLP-1 is causing. If you take both medications, your thyroid levels (TSH, free T4) should be monitored more frequently and your levothyroxine dose may need to be adjusted downward.
This interaction appears specific to oral semaglutide (Rybelsus). Injectable semaglutide (Ozempic, Wegovy) and injectable tirzepatide (Mounjaro) have not shown the same magnitude of effect, likely because the injectable forms do not pass through the GI tract. However, the slower gastric emptying from any GLP-1 agonist could still subtly alter absorption of oral medications, so monitoring thyroid levels is prudent regardless of formulation.
Supplements to Avoid on GLP-1 Medications
Garcinia Cambogia
Garcinia cambogia extracts contain hydroxycitric acid (HCA), marketed for appetite suppression and fat burning. The evidence for weight loss benefits in humans is weak at best — a 2011 systematic review found minimal effect sizes that barely reached statistical significance.
The concern on GLP-1 therapy is compounding. GLP-1 medications already suppress appetite powerfully through well-understood receptor mechanisms. Adding an unregulated appetite suppressant on top introduces risk without meaningful added benefit. Garcinia has been associated with reports of liver toxicity in some case studies, and the combination of hepatic stress plus the metabolic shifts from aggressive weight loss on GLP-1 drugs is not a combination anyone should experiment with casually.
Bottom line: If the GLP-1 medication is working as intended, garcinia cambogia adds nothing useful. If it is not working, the answer is dose adjustment with your physician, not stacking over-the-counter appetite suppressants.
Ephedra and Ephedrine-Containing Supplements
Ephedra (Ephedra sinica) and its alkaloid ephedrine are potent sympathomimetic stimulants that were banned from dietary supplements by the FDA in 2004 due to cardiovascular risks including heart attack, stroke, and sudden death. Despite the ban, ephedra-containing products still circulate through supplement marketplaces and import channels.
The cardiovascular risks of ephedra are unacceptable on their own. Combined with a GLP-1 medication — which itself can cause increased heart rate in some users (semaglutide trials showed a mean increase of 1–4 beats per minute) — the stimulant effects create unnecessary cardiac risk.
Ephedra is banned by the FDA for good reason. No weight loss supplement containing ephedra, ephedrine, or Ma Huang should be taken under any circumstances, and especially not in combination with GLP-1 medications. The cardiovascular risk profile is severe.
Bitter Orange (Synephrine)
After the ephedra ban, bitter orange (Citrus aurantium) became the supplement industry's replacement stimulant. Its active compound, synephrine, is structurally similar to ephedrine and produces qualitatively similar sympathomimetic effects — increased heart rate, vasoconstriction, and elevated blood pressure — though at lower potency per milligram.
The same cardiovascular concerns apply. On GLP-1 therapy, where your cardiovascular system is already adapting to significant metabolic changes and rapid weight loss, adding a stimulant that raises blood pressure and heart rate is not justified by the marginal thermogenic effect synephrine provides.
Bitter orange also appears in many "fat burner" and "metabolism booster" blends, sometimes not prominently listed. Check ingredient labels carefully — Citrus aurantium extract, synephrine, and "bitter orange peel extract" all refer to the same compound.
High-Dose Caffeine Supplements
Moderate coffee consumption (200–400 mg caffeine daily from beverages) is generally well-tolerated on GLP-1 therapy and has its own evidence base for metabolic benefits. The concern is with concentrated caffeine supplements — pills, powders, and pre-workout formulations delivering 300–600 mg per serving.
GLP-1 medications can cause nausea, especially during dose escalation. High-dose caffeine on top amplifies GI distress. The combination of stimulant-driven appetite suppression plus GLP-1-driven appetite suppression can push caloric intake dangerously low, accelerating muscle loss and micronutrient deficiency.
If you use caffeine, keep it moderate and from food sources (coffee, tea) rather than concentrated supplements. Our Caffeine Calculator can help you track your daily intake and timing.
Unregulated "GLP-1 Support" Blends
The supplement market has flooded with products marketed as "GLP-1 activators," "natural Ozempic," or "semaglutide support." Most contain familiar compounds — berberine, chromium, inositol, fiber blends — at varying doses and combinations, with aggressive marketing claims.
The problem is not that these individual ingredients are dangerous. Berberine, for example, has legitimate metabolic effects. The problem is that if you are already on a prescription GLP-1 medication, stacking additional metabolic-modifying supplements adds unpredictable interactions without established benefit.
If your prescribing physician has put you on semaglutide or tirzepatide, your GLP-1 pathway is already being activated at pharmaceutical-grade potency. Adding over-the-counter compounds that target the same or adjacent pathways does not enhance the effect — it just adds variables that make side effects harder to attribute and manage.
Building a Practical GLP-1 Supplement Stack
For users who want a streamlined approach, here is what a reasonable evidence-based stack may look like:
| Supplement | Why on GLP-1 | Dose Range | Timing |
|---|---|---|---|
| Protein (whey/plant) | Preserve lean mass during weight loss | 25-40g, 2-3x daily | Between meals or post-workout |
| Vitamin D3 | Reduced dietary intake + fat-soluble absorption risk | 2,000-4,000 IU | With fattiest meal |
| Vitamin B12 | Reduced absorption, especially on oral semaglutide | 1,000-2,000 mcg | Morning, any time |
| Magnesium glycinate | Cramps, sleep, electrolyte shifts from weight loss | 200-400 mg | Evening, before bed |
| Zinc picolinate | Supports immune function and protein synthesis | 15-30 mg | With food, away from iron |
| Omega-3 (EPA/DHA) | Anti-inflammatory, reduced dietary fish intake | 1,000-2,000 mg combined | With food containing fat |
| Probiotic | GI side effect management | 10B+ CFU, specified strains | Morning, empty stomach |
This is not a universal prescription — individual needs vary based on bloodwork, diet, exercise level, and which GLP-1 medication you are on. The point is to address the nutrient gaps that GLP-1 therapy predictably creates, while avoiding the supplements that add risk without benefit.
Be the first to try Prova
We're building an app to track whether glp1-supplements actually works. Join the waitlist.
What to Monitor
If you are on GLP-1 therapy long-term, periodic bloodwork can catch deficiencies before symptoms develop. Key markers to track:
- 25-hydroxyvitamin D — target 40–60 ng/mL
- Serum B12 + methylmalonic acid — especially on oral semaglutide
- Serum ferritin — check before starting iron supplementation
- RBC magnesium (more accurate than serum magnesium)
- Zinc and copper — if supplementing zinc long-term
- TSH and free T4 — if taking levothyroxine concurrently
- Complete metabolic panel — general baseline
Testing every 6 months is reasonable for most users. More frequent testing during the first year of GLP-1 therapy, when metabolic changes are most rapid, may be prudent.
For a broader view of which biomarkers matter and when, see our guide to biomarkers by age.